<!DOCTYPE html>
<html>
<head>
<meta charset="UTF-8"/>
<title>discharge_letter_thompson_2pages</title>
<meta name="generator" content="Docling HTML Serializer"/>
<style>
    html {
        background-color: #f5f5f5;
        font-family: Arial, sans-serif;
        line-height: 1.6;
    }
    body {
        max-width: 800px;
        margin: 0 auto;
        padding: 2rem;
        background-color: white;
        box-shadow: 0 0 10px rgba(0,0,0,0.1);
    }
    h1, h2, h3, h4, h5, h6 {
        color: #333;
        margin-top: 1.5em;
        margin-bottom: 0.5em;
    }
    h1 {
        font-size: 2em;
        border-bottom: 1px solid #eee;
        padding-bottom: 0.3em;
    }
    table {
        border-collapse: collapse;
        margin: 1em 0;
        width: 100%;
    }
    th, td {
        border: 1px solid #ddd;
        padding: 8px;
        text-align: left;
    }
    th {
        background-color: #f2f2f2;
        font-weight: bold;
    }
    figure {
        margin: 1.5em 0;
        text-align: center;
    }
    figcaption {
        color: #666;
        font-style: italic;
        margin-top: 0.5em;
    }
    img {
        max-width: 100%;
        height: auto;
    }
    pre {
        background-color: #f6f8fa;
        border-radius: 3px;
        padding: 1em;
        overflow: auto;
    }
    code {
        font-family: monospace;
        background-color: #f6f8fa;
        padding: 0.2em 0.4em;
        border-radius: 3px;
    }
    pre code {
        background-color: transparent;
        padding: 0;
    }
    .formula {
        text-align: center;
        padding: 0.5em;
        margin: 1em 0;
        background-color: #f9f9f9;
    }
    .formula-not-decoded {
        text-align: center;
        padding: 0.5em;
        margin: 1em 0;
        background: repeating-linear-gradient(
            45deg,
            #f0f0f0,
            #f0f0f0 10px,
            #f9f9f9 10px,
            #f9f9f9 20px
        );
    }
    .page-break {
        page-break-after: always;
        border-top: 1px dashed #ccc;
        margin: 2em 0;
    }
    .key-value-region {
        background-color: #f9f9f9;
        padding: 1em;
        border-radius: 4px;
        margin: 1em 0;
    }
    .key-value-region dt {
        font-weight: bold;
    }
    .key-value-region dd {
        margin-left: 1em;
        margin-bottom: 0.5em;
    }
    .form-container {
        border: 1px solid #ddd;
        padding: 1em;
        border-radius: 4px;
        margin: 1em 0;
    }
    .form-item {
        margin-bottom: 0.5em;
    }
    .image-classification {
        font-size: 0.9em;
        color: #666;
        margin-top: 0.5em;
    }
</style>
</head>
<body>
<div class='page'>
<h2>Department of Internal Medicine and Oncology</h2>
<h2>Discharge Summary</h2>
<p>Patient: Noah J. Thompson (DOB 1969-01-30, MRN 451237)</p>
<p>Date of Discharge: 2025-09-28</p>
<h2>Clinical Course</h2>
<p>The patient was admitted for evaluation and treatment of a colonic mass detected on screening colonoscopy. He has a background of type 2 diabetes mellitus with suboptimal control. Imaging studies (Colonoscopy and CT abdomen/pelvis (sigmoid colon mass)) confirmed the presence of a tumor in the sigmoid colon. Surgical resection was performed. Pathology confirmed adenocarcinoma, TNM stage II (pT3, pN0, M0), with no nodal or metastatic spread. The hospital stay was uncomplicated, and post-operative recovery was stable.</p>
<h2>Laboratory Results</h2>
<table><tbody><tr><th>Test</th><th>Result</th></tr><tr><td>HbA1c</td><td>8.2 %</td></tr><tr><td>Fasting Glucose</td><td>168 mg/dL</td></tr><tr><td>Creatinine</td><td>1.0 mg/dL</td></tr><tr><td>eGFR</td><td>82 mL/min/1.73mÂ²</td></tr><tr><td>Total Cholesterol</td><td>210 mg/dL</td></tr></tbody></table>
<h2>Medications at Discharge</h2>
<ul>
<li style="list-style-type: '- ';">Metformin 1000 mg BID</li>
<li style="list-style-type: '- ';">Atorvastatin 20 mg QD</li>
<li style="list-style-type: '- ';">Enalapril 10 mg QD</li>
</ul>
<h2>Follow-Up</h2>
<p>The patient should attend oncology clinic within 3 weeks to discuss adjuvant therapy considerations. A follow-up with the endocrinology outpatient clinic is scheduled to optimize diabetes management. Routine surveillance colonoscopy is advised in one year. Patient education regarding diet, glucose monitoring, and lifestyle modification was reinforced.</p>
<p>Disclaimer: This is a synthetic document created for software testing purposes only. It is not for clinical use or to be interpreted as a medical device output.</p>
</div>
</body>
</html>